Tryptophanyl Substitutions in Apomyoglobin Determine Protein Aggregation and Amyloid-like Fibril Formation at Physiological pH*

Myoglobin is an α-helical globular protein that contains two highly conserved tryptophan residues located at positions 7 and 14 in the N-terminal region of the protein. Replacement of both indole residues with phenylalanine residues, i.e. W7F/W14F, results in the expression of an unstable, not correctly folded protein that does not bind the prosthetic group. Here we report data (Congo red and thioflavine T binding assay, birefringence, and electron microscopy) showing that the double Trp/Phe replacements render apomyoglobin molecules highly susceptible to aggregation and amyloid-like fibril formation under physiological conditions in which most of the wild-type protein is in the native state. In refolding experiments, like the wild-type protein, the W7F/W14F apomyoglobin mutant formed a soluble, partially folded helical state between pH 2.0 and pH 4.0. A pH increase from 4.0 to 7.0 restored the native structure only in the case of the wild-type protein and determined aggregation of W7F/W14F. The circular dichroism spectrum recorded immediately after neutralization showed that the polypeptide consists mainly of β-structures. In conclusion, under physiological pH conditions, some mutations that affect folding may cause protein aggregation and the formation of amyloid-like fibrils.

[1]  A. Fersht,et al.  Loss of a metal-binding site in gelsolin leads to familial amyloidosis–Finnish type , 2002, Nature Structural Biology.

[2]  J. Kelly,et al.  Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca2+ stabilization , 2001, The EMBO journal.

[3]  V. Uversky,et al.  Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.

[4]  Christopher M. Dobson,et al.  Amyloid fibrils from muscle myoglobin , 2001, Nature.

[5]  C. Yu,et al.  Structural Events during the Refolding of an All β-Sheet Protein* , 2001, The Journal of Biological Chemistry.

[6]  D. J. Douglas,et al.  Methanol-induced conformations of myoglobin at pH 4.0. , 2000, Biochemistry.

[7]  R. Casadio,et al.  The effect of tryptophanyl substitution on folding and structure of myoglobin. , 2000, European journal of biochemistry.

[8]  B. W. Erickson,et al.  Betabellins 15D and 16D, de Novo designed beta-sandwich proteins that have amyloidogenic properties. , 2000, Journal of structural biology.

[9]  H. Fabian,et al.  Conversion of yeast phosphoglycerate kinase into amyloid‐like structure , 2000, Proteins.

[10]  C M Dobson,et al.  Mutational analysis of the propensity for amyloid formation by a globular protein , 2000, The EMBO journal.

[11]  M. Hecht,et al.  De novo amyloid proteins from designed combinatorial libraries. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[13]  Peter T. Lansbury,et al.  Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease† , 1999 .

[14]  Lars Terenius,et al.  A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation* , 1999, The Journal of Biological Chemistry.

[15]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Lansbury Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Glockshuber,et al.  Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. , 1999, Biochemistry.

[18]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[19]  Max F. Perutz,et al.  Glutamine repeats and neurodegenerative diseases: molecular aspects. , 1999, Trends in biochemical sciences.

[20]  W. Surewicz,et al.  Familial Mutations and the Thermodynamic Stability of the Recombinant Human Prion Protein* , 1998, The Journal of Biological Chemistry.

[21]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[22]  E. Bismuto,et al.  Apomyoglobin folding intermediates characterized by the hydrophobic fluorescent probe 8-anilino-1-naphthalene sulfonate. , 1998, Biochimica et biophysica acta.

[23]  R. L. Baldwin,et al.  Two forms of the pH 4 folding intermediate of apomyoglobin. , 1998, Journal of molecular biology.

[24]  H. Jane Dyson,et al.  Structural and dynamic characterization of partially folded states of apomyoglobin and implications for protein folding , 1998, Nature Structural Biology.

[25]  R. Pappu,et al.  The early folding kinetics of apomyoglobin , 1998, Protein science : a publication of the Protein Society.

[26]  R. Dyer,et al.  Structural heterogeneity of the various forms of apomyoglobin; Implications for protein folding , 1997, Protein science : a publication of the Protein Society.

[27]  P. Wright,et al.  Is apomyoglobin a molten globule? Structural characterization by NMR. , 1996, Journal of molecular biology.

[28]  Michael S. Kay,et al.  Packing interactions in the apomyglobin folding intermediate , 1996, Nature Structural Biology.

[29]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[30]  E. Bismuto,et al.  Solvent and thermal denaturation of the acidic compact state of apomyoglobin , 1994, FEBS letters.

[31]  P E Wright,et al.  Formation of a molten globule intermediate early in the kinetic folding pathway of apomyoglobin. , 1993, Science.

[32]  W. L. Jorgensen,et al.  Molecular dynamics simulations of the unfolding of apomyoglobin in water. , 1993, Biochemistry.

[33]  H. Levine,et al.  Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.

[34]  E. Bismuto,et al.  Salt-induced refolding of myoglobin at acidic pH: molecular properties of a partly folded intermediate. , 1992, Archives of biochemistry and biophysics.

[35]  K. Higuchi,et al.  Kinetic analysis of amyloid fibril polymerization in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[36]  P E Wright,et al.  Structural characterization of a partly folded apomyoglobin intermediate. , 1990, Science.

[37]  A. Fink,et al.  Phase diagram for acidic conformational states of apomyoglobin. , 1990, Journal of molecular biology.

[38]  J. Pettegrew,et al.  Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  R. L. Baldwin,et al.  Use of site-directed mutagenesis to destabilize native apomyoglobin relative to folding intermediates. , 1989, Biochemistry.

[40]  G. Brayer,et al.  Horse heart metmyoglobin. A 2.8-A resolution three-dimensional structure determination. , 1988, The Journal of biological chemistry.

[41]  S. Sligar,et al.  High-level expression of sperm whale myoglobin in Escherichia coli. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[43]  H. Edelhoch,et al.  Spectroscopic determination of tryptophan and tyrosine in proteins. , 1967, Biochemistry.

[44]  D. Kirschner,et al.  A beta fibrillogenesis: kinetic parameters for fibril formation from congo red binding. , 2000, Journal of structural biology.

[45]  W. Klunk,et al.  Quantifying amyloid by congo red spectral shift assay. , 1999, Methods in enzymology.

[46]  D. Selkoe,et al.  Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[47]  C. Blake,et al.  The structure of amyloid fibrils by electron microscopy and X-ray diffraction. , 1997, Advances in protein chemistry.

[48]  J T Yang,et al.  Calculation of protein conformation from circular dichroism. , 1986, Methods in enzymology.

[49]  F. Teale,et al.  Cleavage of the haem-protein link by acid methylethylketone. , 1959, Biochimica et biophysica acta.